← Every firm
Reliance Life Sciences Private Limited FDA Recalls
4 recalls on file across drugs, 0 of them Class I and 4 still open. Matched by name to RS.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Class IIJun 24, 2026Lack of Sterility Assurance |
| Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, ManufacturClass IIJun 24, 2026Lack of Sterility Assurance |
| Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, ManufacturClass IIJun 24, 2026Lack of Sterility Assurance |
| Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx onlClass IIJun 24, 2026Lack of Sterility Assurance |